We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ASPHF market cap is 1.87B. The company's latest EPS is CNY -3.1895 and P/E is -2.02.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 14.51M | 12.45M | 27.91M | 209.71M | 221.98M |
| Operating Income | -1.5B | -693.86M | -920.11M | -853.21M | -872.96M |
| Net Income | -1.48B | -677.61M | -782.42M | -882.92M | -925.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 1.21B | 1.73B | 2.94B | 2.83B | 2.5B |
| Total Liabilities | 314.58M | 884.42M | 1.71B | 2.42B | 2.43B |
| Total Equity | 890.48M | 846.62M | 1.23B | 408.66M | 70.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -460.31M | -609.96M | -604.68M | -653.92M | -726.08M |
| Investing | -201.33M | -107.37M | -466.52M | -384.61M | 21.92M |
| Financing | 442.36M | 1.04B | 1.78B | 619.27M | 368.75M |
| Market Cap | 1.87B |
| Price to Earnings Ratio | -2.02 |
| Price to Sales Ratio | 8.43 |
| Price to Cash Ratio | 1.8 |
| Price to Book Ratio | 26.5 |
| Dividend Yield | - |
| Shares Outstanding | 290.21M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 144.32% |
| 52 Week High | 6.45 |
| 52 Week Low | 2.35 |
| Spread (Intraday) | 2.6 (36.88%) |
| Company Name | Ascentage Pharma Group International (PK) |
| Address |
walkers corporate limited george town KY1-9008 |
| Website | https://www.ascentagepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
